ProfileGDS4516 / 229797_at
TitleColorectal cancer: laser microdissected tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 1 stage: 2a stage: 2b stage: 3a stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM537341 GSM537345 GSM537355 GSM537366 GSM537370 GSM537380 GSM537392 GSM537415 GSM537417 GSM537422 GSM537423 GSM537427 GSM537430 GSM537336 GSM537337 GSM537348 GSM537349 GSM537356 GSM537361 GSM537374 GSM537377 GSM537378 GSM537379 GSM537383 GSM537388 GSM537395 GSM537400 GSM537404 GSM537409 GSM537418 GSM537425 GSM537333 GSM537342 GSM537347 GSM537350 GSM537362 GSM537363 GSM537368 GSM537376 GSM537381 GSM537386 GSM537398 GSM537402 GSM537405 GSM537371 GSM537421 GSM537424 GSM537432 GSM537331 GSM537332 GSM537334 GSM537338 GSM537353 GSM537357 GSM537358 GSM537375 GSM537389 GSM537390 GSM537393 GSM537399 GSM537407 GSM537408 GSM537428 GSM537354 GSM537410 GSM537413 GSM537396 GSM537397 GSM537330 GSM537369 GSM537373 GSM537401 GSM537343 GSM537367 GSM537382 GSM537385 GSM537391 GSM537419 GSM537420 GSM537429 GSM537431 GSM537387 GSM537414 GSM537433 GSM537335 GSM537339 GSM537340 GSM537344 GSM537346 GSM537351 GSM537352 GSM537359 GSM537360 GSM537364 GSM537365 GSM537372 GSM537384 GSM537394 GSM537403 GSM537406 GSM537411 GSM537412 GSM537416 GSM537426 60% 45% 75% 70% 57% 44% 59% 91% 52% 42% 43% 43% 41% 85% 39% 65% 71% 42% 66% 45% 38% 89% 37% 46% 50% 46% 52% 87% 60% 79% 55% 93% 44% 48% 45% 52% 99% 80% 65% 73% 91% 50% 68% 80% 41% 65% 40% 73% 90% 31% 46% 45% 77% 71% 50% 40% 50% 40% 46% 54% 91% 57% 34% 72% 48% 97% 85% 83% 56% 43% 87% 81% 92% 78% 76% 56% 52% 73% 82% 51% 96% 76% 37% 69% 47% 95% 74% 40% 57% 76% 59% 96% 48% 46% 46% 39% 84% 39% 50% 58% 81% 90% 83% 86% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM537341patient 115, cancer, LCM [OPG study]6.1037760
GSM537345patient 119, cancer, LCM [OPG study]5.0760645
GSM537355patient 138, cancer, LCM [OPG study]7.3526475
GSM537366patient 154, cancer, LCM [OPG study]6.8535770
GSM537370patient 022, cancer, LCM [OPG study]5.829357
GSM537380patient 037, cancer, LCM [OPG study]5.0709944
GSM537392patient 077, cancer, LCM [OPG study]5.9847559
GSM537415patient 032, cancer, LCM [OPG study]9.7095491
GSM537417patient 042, cancer, LCM [OPG study]5.6236652
GSM537422patient 059, cancer, LCM [OPG study]4.9950442
GSM537423patient 064, cancer, LCM [OPG study]5.0195943
GSM537427patient 084, cancer, LCM [OPG study]4.9614243
GSM537430patient 090, cancer, LCM [OPG study]4.8773441
GSM537336patient 107, cancer, LCM [OPG study]8.5788185
GSM537337patient 108, cancer, LCM [OPG study]4.7098839
GSM537348patient 124, cancer, LCM [OPG study]6.4686665
GSM537349patient 125, cancer, LCM [OPG study]6.980471
GSM537356patient 139, cancer, LCM [OPG study]4.9451342
GSM537361patient 147, cancer, LCM [OPG study]6.4555966
GSM537374patient 026, cancer, LCM [OPG study]5.1512445
GSM537377patient 033, cancer, LCM [OPG study]4.778738
GSM537378patient 034, cancer, LCM [OPG study]9.2298189
GSM537379patient 036, cancer, LCM [OPG study]4.721237
GSM537383patient 046, cancer, LCM [OPG study]5.1385246
GSM537388patient 063, cancer, LCM [OPG study]5.4567350
GSM537395patient 082, cancer, LCM [OPG study]5.126746
GSM537400patient 099, cancer, LCM [OPG study]5.5169352
GSM537404patient 129, cancer, LCM [OPG study]8.7143987
GSM537409patient 141, cancer, LCM [OPG study]6.0902460
GSM537418patient 044, cancer, LCM [OPG study]7.8936179
GSM537425patient 070, cancer, LCM [OPG study]5.7053355
GSM537333patient 102, cancer, LCM [OPG study]9.9060193
GSM537342patient 116, cancer, LCM [OPG study]5.0900744
GSM537347patient 123, cancer, LCM [OPG study]5.3464448
GSM537350patient 127, cancer, LCM [OPG study]5.1781545
GSM537362patient 148, cancer, LCM [OPG study]5.5423252
GSM537363patient 150, cancer, LCM [OPG study]12.246299
GSM537368patient 156, cancer, LCM [OPG study]7.8799280
GSM537376patient 031, cancer, LCM [OPG study]6.4426465
GSM537381patient 038, cancer, LCM [OPG study]7.1681573
GSM537386patient 057, cancer, LCM [OPG study]9.459991
GSM537398patient 094, cancer, LCM [OPG study]5.4157950
GSM537402patient 109, cancer, LCM [OPG study]6.71368
GSM537405patient 130, cancer, LCM [OPG study]7.7661980
GSM537371patient 023, cancer, LCM [OPG study]4.868341
GSM537421patient 055, cancer, LCM [OPG study]6.5119865
GSM537424patient 065, cancer, LCM [OPG study]4.8503740
GSM537432patient 097, cancer, LCM [OPG study]7.2355573
GSM537331patient 100, cancer, LCM [OPG study]9.3569990
GSM537332patient 101, cancer, LCM [OPG study]4.3681331
GSM537334patient 103, cancer, LCM [OPG study]5.2069546
GSM537338patient 110, cancer, LCM [OPG study]5.110645
GSM537353patient 135, cancer, LCM [OPG study]7.5904377
GSM537357patient 142, cancer, LCM [OPG study]7.0317571
GSM537358patient 143, cancer, LCM [OPG study]5.4057550
GSM537375patient 030, cancer, LCM [OPG study]4.8496340
GSM537389patient 068, cancer, LCM [OPG study]5.3703950
GSM537390patient 072, cancer, LCM [OPG study]4.7942740
GSM537393patient 078, cancer, LCM [OPG study]5.1329846
GSM537399patient 095, cancer, LCM [OPG study]5.7239454
GSM537407patient 133, cancer, LCM [OPG study]9.2784191
GSM537408patient 140, cancer, LCM [OPG study]5.8708957
GSM537428patient 086, cancer, LCM [OPG study]4.5322334
GSM537354patient 136, cancer, LCM [OPG study]7.1077472
GSM537410patient 146, cancer, LCM [OPG study]5.2956348
GSM537413patient 027, cancer, LCM [OPG study]11.289297
GSM537396patient 083, cancer, LCM [OPG study]8.5900585
GSM537397patient 088, cancer, LCM [OPG study]8.3882983
GSM537330patient 006, cancer, LCM [OPG study]5.7877856
GSM537369patient 015, cancer, LCM [OPG study]5.0010743
GSM537373patient 025, cancer, LCM [OPG study]8.8809787
GSM537401patient 106, cancer, LCM [OPG study]8.0177381
GSM537343patient 117, cancer, LCM [OPG study]9.6932792
GSM537367patient 155, cancer, LCM [OPG study]7.6119178
GSM537382patient 041, cancer, LCM [OPG study]7.4900476
GSM537385patient 053, cancer, LCM [OPG study]5.8040656
GSM537391patient 073, cancer, LCM [OPG study]5.5926252
GSM537419patient 045, cancer, LCM [OPG study]7.1153873
GSM537420patient 052, cancer, LCM [OPG study]7.9924482
GSM537429patient 089, cancer, LCM [OPG study]5.4181251
GSM537431patient 096, cancer, LCM [OPG study]10.335596
GSM537387patient 061, cancer, LCM [OPG study]7.511176
GSM537414patient 028, cancer, LCM [OPG study]4.6575237
GSM537433patient 098, cancer, LCM [OPG study]6.8092969
GSM537335patient 104, cancer, LCM [OPG study]5.2139447
GSM537339patient 111, cancer, LCM [OPG study]10.553495
GSM537340patient 113, cancer, LCM [OPG study]7.2039474
GSM537344patient 118, cancer, LCM [OPG study]4.8339240
GSM537346patient 011, cancer, LCM [OPG study]5.8408557
GSM537351patient 128, cancer, LCM [OPG study]7.5111576
GSM537352patient 134, cancer, LCM [OPG study]6.0213959
GSM537359patient 144, cancer, LCM [OPG study]10.865796
GSM537360patient 145, cancer, LCM [OPG study]5.3130348
GSM537364patient 152, cancer, LCM [OPG study]5.2000346
GSM537365patient 153, cancer, LCM [OPG study]5.1672446
GSM537372patient 024, cancer, LCM [OPG study]4.8339239
GSM537384patient 048, cancer, LCM [OPG study]8.3605584
GSM537394patient 081, cancer, LCM [OPG study]4.8088139
GSM537403patient 121, cancer, LCM [OPG study]5.4097250
GSM537406patient 131, cancer, LCM [OPG study]5.9780458
GSM537411patient 149, cancer, LCM [OPG study]7.892881
GSM537412patient 019, cancer, LCM [OPG study]9.1911790
GSM537416patient 035, cancer, LCM [OPG study]8.3619483
GSM537426patient 079, cancer, LCM [OPG study]8.8032186